TABLE 1.
Expt | Virusa | Infectivity (PFU/ml)b | CT MHVc | CT VSVd | Relative MHV RNA contente | Relative specific infectivityf |
---|---|---|---|---|---|---|
1 | rJ.6 | 1.1 × 106 | 24 (1.62-fold) | 16.1 (0.87-fold) | 1.86 | 1.18 |
rJ.6-KO | 5 × 105 | 24.7 | 15.9 | 1 | 1 | |
2 | rJ.6 | 2 × 105 | 24 (7.46-fold) | 18.1 (1.62-fold) | 4.6 | 0.87 |
rJ.6-KO | 5 × 104 | 26.9 | 18.8 | 1 | 1 |
In two independent experiments, rJ.6 and rJ.6-KO were grown in parallel and collected from infected 17cl1 cell supernatants at 18 h postinfection.
Infectivities were determined by plaque assays on 17cl1 indicator cells.
CT values for each virus pair were determined by RT-qPCR, and the differences in the CT values were converted to the changes in the differences (n-fold), using 2ΔCT = change in difference (n-fold).
CT values for the VSV RNA extracted from the VSV-spiked samples were determined by parallel RT-qPCR, and the CT differences were converted to the changes in the differences (n-fold).
Relative MHV RNA contents were determined by dividing the change in MHV RNA levels by the change in control VSV RNA levels. MHV RNA contents were normalized relative to rJ.6-KO.
Relative specific infectivity values (PFU/unit of genomic RNA) were determined by dividing the PFU ratios by the RNA ratios for each virus pair.